Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults

Clinical trial NCT02030301 · COMPLETED

Trial details

NCT number: NCT02030301
Sponsor: Vical
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Genital Herpes Simplex Type 2

Start date: 2013-12-01
Primary completion: 2015-06-01
Enrollment: 165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.